Protective Effects of Simvastatin, a Lipid Lowering Agent, against Oxidative Damage in Experimental Diabetic Rats
Figure 5
Effect of simvastatin (SMV) and glibenclamide treatment on liver thiobarbituric acid reactive substances (TBARS) in liver (a) and kidney (b) in normal and streptozotocin-induced diabetic rats. Data are expressed as means ± SEM (). *Significantly different from control group ().